Leonhardt Harry J Insider Trades

Insider Trading History

Track insider trading activity for Leonhardt Harry J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Poseida Therapeutics
Poseida Therapeutics PSTX
GC & Chief Compliance Officer
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.19M 125,283 shares
$9.50
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
GC & Chief Compliance Officer
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.52M 160,385 shares
$9.50
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
GC & Chief Compliance Officer
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$2.01M 223,640 shares
$9.00
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
GC & Chief Compliance Officer
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.06M 111,700 shares
$9.50
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
GC & Chief Compliance Officer
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.25M 137,000 shares
$9.15
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
GC & Chief Compliance Officer
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$689k 72,568 shares
$9.50
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
GC & Chief Compliance Officer
Holding Value $2.04M 214,640 shares
Last Trade
Mar 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$67.3k 16,306 shares
$4.13
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
GC & Chief Compliance Officer
Holding Value $2.19M 230,946 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$461k 111,700 shares
$4.13
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
GC & Chief Compliance Officer
Holding Value $1.37M 144,203 shares
Last Trade
Mar 01, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$23.1k 4,323 shares
$5.35
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
GC & Chief Compliance Officer
Holding Value $1.41M 148,526 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$670k 125,283 shares
$5.35
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
GC & Chief Compliance Officer
Holding Value $689k 72,568 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$248k 72,568 shares
$3.42
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
GC & Chief Compliance Officer
Holding Value $1.3M 137,000 shares
Last Trade
Feb 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.25M 137,000 shares
$9.15
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
GC & Chief Compliance Officer
Holding Value $0 0 shares
Last Trade
Sep 15, 2020 Sale
$1.59M 160,385 shares
$9.92
$9.50
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, GC
Holding Value $4.75M 66,373 shares
Last Trade
Apr 13, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$39.3k 2,377 shares
$16.54
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, GC
Holding Value $4.92M 68,750 shares
Last Trade
Apr 13, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$114k 6,875 shares
$16.54
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, GC
Holding Value $0 0 shares
Last Trade
Apr 13, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$114k 6,875 shares
$16.54
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, GC
Holding Value $1.63M 22,784 shares
Last Trade
Feb 22, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$191k 11,392 shares
$16.81
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, GC
Holding Value $4.43M 61,875 shares
Last Trade
Feb 22, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$66.2k 3,939 shares
$16.81
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, GC
Holding Value $4.71M 65,814 shares
Last Trade
Feb 22, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$191k 11,392 shares
$16.81
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, GC
Holding Value $1.68M 23,425 shares
Last Trade
Feb 14, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$129k 7,809 shares
$16.54
$71.60

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up